Stay updated on XmAb20717 in Biliary Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.

Latest updates to the XmAb20717 in Biliary Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check92 days agoChange DetectedA new addition was made on December 18, 2024, while a deletion occurred on May 7, 2024.SummaryDifference0.7%
Stay in the know with updates to XmAb20717 in Biliary Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.